Skip to content
Medical Health Aged Care, Seniors Interest

Monash Expert: Heart Failure Awareness Week

Monash University 2 mins read

This week (June 19-25) is Heart Failure Awareness Week, which educates about the risk and prevalence of heart failure. hearts4heart says more than 500,000 Australians experience heart failure, which will rise with the prevalence of heart attacks, longer life expectancy, and shifting health and lifestyle trends.

What is heart failure?

Heart failure doesn’t mean that your heart has stopped, but it is ‘failing’ to keep up with your body’s demands. The heart is unable to pump enough blood through the body to meet its nutritional needs, either because it is unable to fill with enough blood, or its pumping action isn’t strong enough, or both.

Symptoms can include any of the following:

  • Shortness of breath during minimal exercise or exertion
  • Needing to use extra pillows when lying down to breathe easier
  • Irregular heartbeat or palpitations
  • Swelling of legs, feet or stomach
  • Coughing/wheezing
  • Weight gain over a short period of time (e.g., more than 2kg over 2 days)
  • Extreme tiredness, low energy or no energy
  • Loss of appetite

Source: hearts4heart

Available to comment:

Associate Professor Ingrid Hopper, Consultant physician Alfred Health and Associate Professor, Chronic disease and Ageing, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University.
Available: Tuesday 20 June, afternoon; Wednesday 21 June, afternoon; Thursday 22 June, afternoon; Friday 23 June, afternoon
Contact details: +61 412 280 579, or [email protected] or Twitter DM: @ingrid_hopper 

  • Heart failure
  • Who is at risk and who
  • Prevention
  • Early detection 

The following can be attributed to Associate Professor Hopper:

“Heart failure is an incredibly common condition and has been described as an epidemic. Roughly 2 per cent of the Australian population are living with heart failure. It’s a disease of older people mostly, as prevalence increases with age, from around 1 per cent for those aged less than 55 years to over 10 per cent of those aged 70 years or over. Both men and women can develop heart failure.

“People with certain diseases and illnesses seem to be more prone to developing heart failure, including people with: high blood pressure (hypertension); coronary heart disease (fatty deposits in arteries); weakened heart muscles from heart attack; heart valves that do not open or close properly; and cardiomyopathy (a disease of the heart muscle). Obesity and diabetes are both associated with an increased risk of developing heart failure, particularly among women. Daily-life risk factors that may contribute to the development of heart failure can include smoking, alcohol consumption, low level of physical activity, poor diet, stress and social isolation.

“Recognising symptoms of heart failure is key to early diagnosis and effective patient management. Symptoms of heart failure can be debilitating with shortness of breath, fatigue and fluid retention, which impacts people’s ability to walk, work and care for themselves. However, symptoms of heart failure can also be quite subtle, and include fatigue, shortness of breath on exercise, or a cough when lying in bed at night.

“If you are concerned that you may have heart failure, you should see your GP for an assessment in the first instance. Your GP may refer you to a heart specialist. There is huge potential to save lives, improve quality of life, and maintain independent living if it is diagnosed early, treated with appropriate medications, and incorporates lifestyle changes. In Heart Failure Awareness Week, it is important to get the message out that although there is currently no cure for heart failure, early detection, medical therapies, and lifestyle changes can help people to manage their condition well and lead productive and fulfilled lives.”

 

More from this category

  • General News, Medical Health Aged Care
  • 12/03/2026
  • 14:07
Parliament of Australia

Public hearing concerning the National Redress Scheme

TheJoint Standing Committee on Implementation of the National Redress Schemewill hold a public hearing in Canberra on Friday, 13 March 2026, for itsinquiry into the continuing operation of the Scheme. Committee Chair, Ms Jodie Belyea MP, said the Committee is grateful for the contributions made in support of the inquiry to date. ‘The National Redress Scheme plays a central role in Australia’s response to institutional child sexual abuse. It is an important program for a significant number of people. The Committee has received a substantial number of submissions in support of our current inquiry, and public hearings over the coming…

  • Energy, Medical Health Aged Care
  • 12/03/2026
  • 12:11
Sweltering Cities

The cost of keeping cool is making Australians sick: New report reveals millions forced to ration cooling during record heat

12 March 2026 Sweltering Cities has today released the findings of its 2026 Summer Survey, exposing a national health crisis driven by the rising cost of keeping cool. With data from more than 2,600 respondents across 766 postcodes, the report proves that for many Australians the high cost of staying cool is having serious physical and mental health impacts. The 2025/26 summer saw 68% of all respondents report feeling unwell due to heat. However, the survey reveals that this burden is falling most heavily on those already struggling with the cost of living. For renters and people with disabilities, the…

  • Medical Health Aged Care
  • 12/03/2026
  • 10:01
Monash University

Monash Researchers Awarded up to $22.4 Million AUD to Develop New Medicines for Restoring Lymphatic Pumping

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to reverse poor lymphatic vessel contraction and transport function, backed by an up to $22.4 million AUD Award from the Advanced Research Projects Agency for Health (ARPA-H). The researchers join ARPA-H’s GLIDE (Groundbreaking Lymphatic Interventions and Drug Exploration) program to transform how both primary lymphatic diseases and common chronic diseases are treated by developing innovative therapeutics that alleviate, repair or regenerate a dysfunctional lymphatic vascular system. Professor Arthur Christopoulos, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, said the work…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.